Skip to main content
BIO CEO & Investor Conference Logo

February 10-11, 2025・New York, NY

BIO CEO & Investor Conference Logo

February 10-11, 2025・New York, NY

2024 Company Presentation Schedule

blue gradient

Company Presentations are sponsored by: 

bioharvest sciences

Loading
Search Filters
  • Therapeutic Focus
  • Date
  • Starttime
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
9:15 AM
  1. Kernal Bio
    Uris
    15 mins
    YUSUF ERKUL, CEO - Kernal Biologics
  2. Aeterna Therapeutics
    Royale
    15 mins
    Dr. Maria Kondratyev, CEO - Aeterna. Therapeutics
  3. Calissa Therapeutics
    Plymouth
    15 mins
    Dr. Jack HU, CEO - Calissa Therapeutics
9:30 AM
  1. Rejuvenation Technologies
    Plymouth
    15 mins
    Glenn Markov, COO - Rejuvenation Technologies
  2. Diakonos Oncology
    Uris
    15 mins
    Anthony Baldor, CFO and Head of Business Development - Diakonos Oncology
  3. Aileron Therapeutics
    Royale
    15 mins
    Dr. Brian Windsor, President and COO - Aileron Therapeutics
9:45 AM
  1. Vasomune Therapeutics Inc
    Royale
    15 mins
    Dr. BRIAN JAHNS, President & Chief Operating Officer - Vasomune Therapeutics inc
  2. Allegro
    Plymouth
    15 mins
    Mr. Lucas Decuypere, CEO - Allegro
10:00 AM
  1. Saghmos Therapeutics
    Plymouth
    15 mins
    Dr. Anna Kazanchyan, Founder and Chief Executive Officer - Saghmos Therapeutics
  2. Processa Pharmaceuticals, Inc.
    Uris
    15 mins
    George NG, Chief Executive Officer - Processa Pharmaceuticals, Inc.
  3. BioHarvest Sciences
    Royale
    15 mins
    Mr. Ian Sobel, Chief Executive Officer - BioHarvest Sciences
10:15 AM
  1. Mercy BioAnalytics
    Plymouth
    15 mins
    Dr. Dawn Mattoon, Chief Executive Officer - Mercy BioAnalytics
  2. SciTech Development
    Uris
    15 mins
    Earle Holesapple, CEO - SciTech Development
  3. Humanetics Corporation
    Royale
    15 mins
    Mr. TIMOTHY MORRIS, Board Member - Humanetics Corporation
10:30 AM
  1. Candel Therapeutics
    Uris
    15 mins
    Paul Peter Tak, President & CEO - Candel Therapeutics
  2. NeuroDex, Inc.
    Plymouth
    15 mins
    Mr. Oded Biran, CEO - NeuroDex, Inc.
  3. ZyVersa Therapeutics, Inc
    Royale
    15 mins
    Steve Glover, Chairman and CEO - ZyVersa Therapeutics, Inc
10:45 AM
  1. Seek Labs
    Plymouth
    15 mins
    Jared Bauer, Chief Executive Officer - Seek Labs
  2. supernova bio Co. Ltd.
    Royale
    15 mins
    Dr. Junkeun Chang, Founder & BOD chairman - supernova bio Co. Ltd.
  3. Indaptus Therapeutics
    Uris
    15 mins
    Jeffrey Meckler, CEO - Indaptus Therapeutics
11:00 AM
  1. Bexion Pharmaceuticals
    Uris
    15 mins
    Mr. Scott Shively, CEO - Bexion Pharmaceuticals
  2. ZWI Therapeutics
    Royale
    15 mins
    Ed Mascioli, CEO - ZWI TX
  3. EosDx Inc.
    Plymouth
    15 mins
    Mr. John Pavlidis, CEO - EosDx Inc.
11:15 AM
  1. Lisata Therapeutics
    Uris
    15 mins
    Dr. David Mazzo, President and Chief Executive Officer - Lisata Therapeutics
  2. Scenic Biotech
    Royale
    15 mins
    Dr. CA (Oscar) Izeboud, CEO - Scenic Biotech
  3. GenEndeavor
    Plymouth
    15 mins
    Mr. Ricardo Mancebo, CEO - Genendeavor
11:30 AM
  1. Cytovation
    Uris
    15 mins
    Dr. Lars Prestegarden, CEO - Cytovation
  2. Jan Biotech, Inc.
    Plymouth
    15 mins
    Dr. janet Huie, CSO, Co-Founder - Jan Biotech, Inc.
  3. Ridgeline Therapeutics
    Royale
    15 mins
    Stan Watowich, CEO - Ridgeline Therapeutics
11:45 AM
  1. Brinter Inc
    Plymouth
    15 mins
    Mr. Tom Alapaattikoski, CEO - Brinter Inc
  2. EVast Bio Inc.
    Royale
    15 mins
    Maximiliano Kunze Küllmer, Business Co-founder - EVast Bio Inc.
  3. Intensity Therapeutics, Inc.
    Uris
    15 mins
    Lew Bender, CEO - Intensity Therapeutics, Inc.
1:00 PM
  1. Protalix Biotherapeuticss
    Plymouth
    15 mins
    Mr. Dror Bashan, President & CEO - Protalix Biotheraeutics
  2. BioInvent International
    Uris
    15 mins
    Mr. Martin Welschof, CEO - BioInvent International
  3. IN8bio
    Royale
    15 mins
    Mr. William Ho, President & CEO - IN8bio
1:15 PM
  1. Cognigenics
    Royale
    15 mins
    Mr. Tom Lytle, Vice President - Cognigenics
  2. Tactical Therapeutics, Inc
    Uris
    15 mins
    Dr. Rashida Karmali, Chief Executive Officer & President - Tactical Therapeutics,Inc
  3. Sernova
    Plymouth
    15 mins
    Cynthia Pussinen, CEO - Sernova Corp.
1:30 PM
  1. Leapfrog Bio
    Uris
    15 mins
    Mr. Greg Vontz, CEO - Leapfrog Bio
  2. Genprex, Inc.
    Plymouth
    15 mins
    Mr. Ryan Confer, Chief Financial Officer - Genprex, Inc.
  3. Tonix Pharmaceuticals
    Royale
    15 mins
    Dr. Seth Lederman, Chief Executive Officer - TONIX Pharmaceuticals
1:45 PM
  1. ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
    Uris
    15 mins
    Dr. Wenzhi Tian, Founder, Chairman & CEO - ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
  2. Ocugen
    Plymouth
    15 mins
    Dr. Shankar Musunuri, Chairman, CEO and Co-Founder - Ocugen, Inc.
  3. Allyx Therapeutics
    Royale
    15 mins
    Timothy Siegert, COO - Allyx Therapeutics
2:00 PM
  1. Carina Biotech Limited
    Uris
    15 mins
    Dr. Deborah Rathjen, CEO - Carina Biotech
  2. CervoMed, Inc.
    Royale
    15 mins
    Dr. John Alam, CEO - CervoMed Inc.
  3. Cell BioEngines, Inc
    Plymouth
    15 mins
    Dr. Ajay Vishwakarma, Founder and CEO - Cell BioEngines, Inc
2:15 PM
  1. Immunis Inc.
    Plymouth
    15 mins
    Dr. Hans Keirstead, Chairman of the Board - Immunis, Inc.
  2. Lyndra Therapeutics
    Royale
    15 mins
    Jessica Ballinger, President & CEO - Lyndra Therapeutics
  3. Avstera Therapeutics Corp.
    Uris
    15 mins
    Karthik Musunuri, CEO & Co-Founder - Avstera Therapeutics Corp.
2:30 PM
  1. Cyclacel Pharmaceuticals, Inc.
    Uris
    15 mins
    Mr. Spiro Rombotis, President and CEO - Cyclacel Pharmaceuticals, Inc.
  2. SIRPant Immunotherapeutics, Inc.
    Plymouth
    15 mins
    Mr. Robert Towarnicki, President & CEO - SIRPant Immunotherapeutics Inc.
  3. NRx Pharmaceuticals
    Royale
    15 mins
    Jonathan Javitt, Chairman and Chief Scientist - NRx Pharma
2:45 PM
  1. Resolution Therapeutics
    Plymouth
    15 mins
    Dr. Amir Hefni, CEO - Resolution Therapeutics
  2. Chimeric Therapeutics
    Uris
    15 mins
    Ms. Jennifer Chow, CEO and Managing Director - Chimeric Therapeutics
  3. Reviva Pharmaceuticals
    Royale
    15 mins
    Dr. Laxminarayan Bhat, CEO - Reviva Pharmaceuticals Inc
3:00 PM
  1. Ziphius
    Royale
    15 mins
    Mr. Chris Cardon, CEO - Ziphius
  2. Rejuvenate Biomed
    Uris
    15 mins
    Dr. Ann BELIEN, Founder & CEO - Rejuvenate Biomed
3:15 PM
  1. SAB Biotherapeutics, Inc.
    Royale
    15 mins
    Samuel Reich, Chairman and CEO - SAB Biotherapeutics
  2. Genesis Healthcare Co.
    Uris
    15 mins
    Mr. Michel Mommejat, Chief Innovation Officer - Genesis Healthcare
  3. Coastar Therapeutics Inc.
    Plymouth
    15 mins
    Eddie Chung, CEO - Coastar Therapeutics Inc.
3:30 PM
  1. Inimmune
    Royale
    15 mins
    Dr. Alan Joslyn, Chief Executive Officer - Inimmune Inc.
  2. Papillon Therapeutics, Inc.
    Plymouth
    15 mins
    Carter Cliff, CEO - Papillon Therapeutics, Inc.
  3. Vincogen Corporation
    Uris
    15 mins
    Mr. Alexander Lai, Chief Technology Officer (CTO) - Vincogen Corporation
3:45 PM
  1. Portal Instruments, Inc.
    Uris
    15 mins
    Dr. Patrick Anquetil, CEO - Portal Instruments
  2. Garuda Therapeutics, Inc.
    Plymouth
    15 mins
    Dr. Dhvanit Shah, President and CEO - Garuda Therapeutics
4:00 PM
  1. Sapience Therapeutics
    Uris
    15 mins
    Barry Kappel, President, CEO & Founder - Sapience Therapeutics
  2. EG 427
    Plymouth
    15 mins
    Mr. Don Haut, Chief Business Officer - EG 427
  3. Diamyd Medical
    Royale
    15 mins
    Dr. Christoph Nowak, Chief Medical and Business Officer - Diamyd Medical
4:15 PM
  1. GeoVax Labs, Inc.
    Royale
    15 mins
    David Dodd, Chairman & CEO - GeoVax Labs, Inc.
  2. Alligator Bioscience
    Uris
    15 mins
    Dr. Soren BREGENHOLT, CEO - Alligator Bioscience
  3. Navega Therapeutics
    Plymouth
    15 mins
    Ana Moreno, CEO and Founder - Navega Therapeutics
4:30 PM
  1. Uvax Bio, LLC
    Royale
    15 mins
    Mr. Kevin O'Neill, Sr. Vice President - Uvax Bio, LLC
  2. Sustained Therapeutics
    Plymouth
    15 mins
    Mr. William Annett, CEO - Sustained Theraeputics
  3. Innova Therapeutics
    Uris
    15 mins
    Dr. Robert ryan, CEO - Innova Therapeutics
4:45 PM
  1. Merlin Biotech, Inc.
    Uris
    15 mins
    Dr. Randall Hyer, CEO - Merlin Biotech, Inc.
  2. Gentas Biotechnology
    Royale
    15 mins
    Jeffrey Carper, Managing Partner - Gentas Biotechnology
  3. Nanoscope Therapeutics
    Plymouth
    15 mins
    Sulagna Bhattacharya, CEO - Nanoscope Therapeutics
9:00 AM
  1. Predictive Oncology
    Uris
    15 mins
    Mr. Raymond Vennare, Chief Executive Officer - Predictive Oncology
  2. AyuVis Research, Inc.
    Plymouth
    15 mins
    suchismita Acharya, Founder & CEO - AyuVis Research, Inc.
9:15 AM
  1. Caledon Bioscience Inc.
    Plymouth
    15 mins
    Mr. Bruce Pritchard, CEO - Caledon Bioscience Inc.
  2. AIVITA Biomedical, Inc.
    Uris
    15 mins
    Hans Keirstead, Chairman & CEO - AiVita Biomedical, Inc.
9:30 AM
  1. Halia Therapeutics
    Plymouth
    15 mins
    Mr. David Bearss, CEO - Halia Therapeutics
  2. Rakuten Medical, Inc.
    Uris
    15 mins
    Mr. Abhijit Bhatia, Chief Operating Officer - Rakuten Medical, Inc.
9:45 AM
  1. Citius Pharmaceuticals, Inc.
    Uris
    15 mins
    Leonard Mazur, Chief Executive Officer - Citius Pharmaceuticals
10:00 AM
  1. Actithera
    Uris
    15 mins
    Dr. Andreas Goutopoulos, CEO - Actithera
  2. Neurocentrx
    Plymouth
    15 mins
    Mr. Jeffrey Roix, CEO - Neurocentrx
10:15 AM
  1. Panavance Therapeutics Inc.
    Uris
    15 mins
    Mr. Greg Bosch, Chairman & CEO - Panavance Therapeutics Inc.
  2. Bionomics Ltd
    Plymouth
    15 mins
    Dr. Spyros Papapetropoulos, President and CEO - Bionomics Inc
10:30 AM
  1. NEWRON PHARMACEUTICALS SPA
    Plymouth
    15 mins
    Mr. STEFAN WEBER, CEO - Newron Pharmaceuticals SpA
  2. Starton Therapeutics
    Uris
    15 mins
    Mr. Pedro Lichtinger, Chairman & CEO - Starton Therapeutics
10:45 AM
  1. Elsie Bio
    Plymouth
    15 mins
    Mr. Kevin Green, COO - Elsie Bio
  2. Oncoteq AG
    Uris
    15 mins
    Mr. Mads Dalsgaard, Chief Executive Officer - Cureteq AG
11:00 AM
  1. ZTI BIOSCIENCES
    Uris
    15 mins
    Mr. Jaden Hyungseok Chang, CEO - ZTI Biosciences
  2. ProMIS Neurosciences
    Plymouth
    15 mins
    Neil Warma, CEO - ProMIS Neurosciences
11:15 AM
  1. Editpep
    Plymouth
    15 mins
    Ms. Genine Winslow, CEO - Editpep
  2. Larkspur Biosciences
    Uris
    15 mins
    Catherine Sabatos-Peyton, CEO - Larkspur Biosciences
11:30 AM
  1. Luminary Therapeutics
    Uris
    15 mins
    Mr. Jeff Liter, CEO - Luminary Therapeutics, Inc.
  2. a:head bio AG
    Plymouth
    15 mins
    Dr. Joshua Bagley, CSO - a:head bio AG
11:45 AM
  1. Ashvattha Therapeutics, Inc
    Plymouth
    15 mins
    Jeffrey Cleland, Chairman, CEO & President - Ashvattha Therapeutics, Inc.
  2. Apricity Health
    Uris
    15 mins
    Dr. Lynda Chin, CEO - Apricity Health
1:00 PM
  1. PTM Therapeutics, Inc.
    Plymouth
    15 mins
    Dr. Jennifer Cheng, Co-founder & CEO - PTM Therapeutics, Inc.
1:15 PM
  1. First Wave BioPharma, Inc.
    Plymouth
    15 mins
    Mr. James Sapirstein, Chairman and CEO - First Wave BioPharma, Inc.
1:30 PM
  1. Jaguar Health, Inc.
    Plymouth
    15 mins
    Dr. Karen Brunke, PhD, Acting CEO - Jaguar Health, Inc.
  2. Reglagene
    Uris
    15 mins
    Richard Austin, CEO - Reglagene
1:45 PM
  1. Satellite Bio
    Uris
    15 mins
    Dr. Laura Lande-Diner, President & CBO - Satellite Bio
  2. Kanglin Biotechnology (Hangzhou) Co., Ltd.
    Plymouth
    15 mins
    Youren Tong, Head of R&D - Kanglin Biotechnology (Hangzhou) Co., Ltd.
2:00 PM
  1. Seragene Therapeutics
    Uris
    15 mins
    Dr. Erika Siren, CEO - Seragene Therapeutics
  2. Alphyn Biologics, Inc.
    Plymouth
    15 mins
    Mr. Neal Koller, CEO - Alphyn Biologics
2:15 PM
  1. IVIEW Therapeutics Inc.
    Plymouth
    15 mins
    Dr. Bo Liang, Chairman & CEO - IVIEW Therapeutics Inc.
  2. Concerto Biosciences
    Uris
    15 mins
    Dr. Cheri Ackerman, CEO & Cofounder - Concerto Biosciences
2:30 PM
  1. ONL Therapeutics
    Plymouth
    15 mins
    Mr. David Esposito, CEO - ONL Therapeutics, Inc.
  2. Intrepid Labs
    Uris
    15 mins
    Dr. Christine Allen, CEO and Cofounder - Intrepid
2:45 PM
  1. Ocuphire
    Plymouth
    15 mins
    Dr. George Magrath, CEO - Ocuphire
3:00 PM
  1. Epion Therapeutics, Inc.
    Plymouth
    15 mins
    Mr. Michael Webb, President & CEO - Epion Therapeutics, Inc.
  2. Nobias Therapeutics
    Uris
    15 mins
    Mr. Neil Inala, CEO - Nobias Therapeutics
3:15 PM
  1. Biograil
    Uris
    15 mins
    Dr. Karsten Lindhardt, CEO - Biograil
3:30 PM
  1. VerImmune Inc
    Uris
    15 mins
    Dr. Joshua wang, Founder/CEO - Washington DC
3:45 PM
  1. Likarda
    Uris
    15 mins
    Dr. Stella Vnook, CEO - Likarda
4:00 PM
  1. CyGenica
    Uris
    15 mins
    Dr. SANGHAMITRA MOBASSARAH NUSRAT JAHAN, Founder, CEO - CyGenica
Testimonials
  • It's the kind of meeting where biotech newsmakers can have productive dialogs with investors and other key players.
    Luke Timmerman
    The Timmerman Report
  • It's the caliber of attendees - biopharma companies on the verge of their next big step and investors looking for smart opportunities - that make BIO CEO & Investor Conference vital to the industry.
    Anna Kazanchyan, MD
    Founder & CEO, Saghmos Therapeutics
  • The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem.
    Philip Ross, MD
    Global Chairman, J.P. Morgan Healthcare Investment Banking
  • The BIO CEO & Investor Conference provides timely and relevant content on the issues driving the business of biotech, along with an invaluable platform for networking and partnering.
    Chris Garabedian
    Chairman and CEO, Xontogeny and Portfolio Manager, PXV Fund

Double Helix

Loading

 

Supporting Bank Sponsor

Loading

 

Premier Sponsors

Loading

Conference Sponsors

Loading

 

Media Partner

Loading

 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP

Search